FIELD: medicine.
SUBSTANCE: as antigens, vaccine contains a cell suspension of pure culture of E. coli colibacillosis, Str. pneumoniae streptococcus agents and rabbit hemorrhagic disease virus prepared by sampling the affected organs of dead rabbits of a local epizootic centre.
EFFECT: invention provides higher specificity and efficacy of the associated colibacillosis, streptococcus and rabbit viral hemorrhagic disease vaccine eliminating an adverse side effect on animals, and also can be used in research and manufacturing facilities involved in biological engineering.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING ASSOCIATED COLIBACILLOSIS, STREPTOCOCCOSIS AND RABBIT VIRAL HEMORRHAGIC DISEASE VACCINE | 2010 |
|
RU2443774C1 |
ASSOCIATED STREPTOCOCCOSIS AND RABBIT VIRAL HEMORRHAGIC DISEASE VACCINE | 2010 |
|
RU2429879C1 |
ASSOCIATED SALMONELLOSIS, ESCHERICHIOSIS AND RABBIT VIRAL HAEMORRHAGIC DISEASE VACCINE | 2012 |
|
RU2510839C2 |
ASSOCIATED PSEUDOMONOSIS AND RABBIT VIRAL HAEMORRHAGIC DISEASE VACCINE | 2013 |
|
RU2531054C1 |
METHOD TO MANUFACTURE VACCINE ASSOCIATED AGAINST STREPTOCOCCOSIS AND VIRUS HAEMORRHAGIC DISEASE OF RABBITS | 2010 |
|
RU2429880C1 |
METHOD FOR PRODUCING ASSOCIATED SALMONELLOSIS, ESCHERICHIOSIS AND RABBIT VIRAL HEMORRHAGIC DISEASE VACCINE | 2012 |
|
RU2496518C1 |
MIXED VACCINE AGAINST COLI-BACTERIOSIS, SALMONELLOSIS AND STREPTOCOCCOSUS IN NUTRIA | 2006 |
|
RU2301681C1 |
ASSOCIATED VACCINE AGAINST COLIBACTERIOSIS, SALMONELLOSIS, STREPTOCOCCOSIS AND ENTEROCOCCAL INFECTION IN NUTRIAS | 2006 |
|
RU2316344C1 |
METHOD OF MANUFACTURING VACCINE, ASSOCIATED AGAINST PSEUDOMONOSIS AND VIRAL RABBIT HAEMORRHAGIC DISEASE | 2013 |
|
RU2553557C2 |
METHOD FOR PREPARING MIXED VACCINE AGAINST COLI-BACTERIOSIS, SALMONELLOSIS AND STREPTOCOCCOSIS IN NUTRIA | 2006 |
|
RU2301077C1 |
Authors
Dates
2012-02-27—Published
2010-06-29—Filed